126 related articles for article (PubMed ID: 11207085)
1. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients.
Holm T; Andreassen AK; Aukrust P; Andersen K; Geiran OR; Kjekshus J; Simonsen S; Gullestad L
Eur Heart J; 2001 Mar; 22(5):428-36. PubMed ID: 11207085
[TBL] [Abstract][Full Text] [Related]
2. Cyclosporine-induced hypertension. Efficacy of omega-3 fatty acids in patients after cardiac transplantation.
Ventura HO; Milani RV; Lavie CJ; Smart FW; Stapleton DD; Toups TS; Price HL
Circulation; 1993 Nov; 88(5 Pt 2):II281-5. PubMed ID: 8222166
[TBL] [Abstract][Full Text] [Related]
3. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM; Carpenter CB; Shapiro ME; Strom TB; Hefty D; Tillman M; Abrams J; Ryan D; Kelley VR
Transplantation; 1995 Feb; 59(3):352-6. PubMed ID: 7871564
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
5. Omega-3 polyunsaturated fatty acid supplements and ambulatory blood pressure monitoring parameters in patients with mild essential hypertension.
Russo C; Olivieri O; Girelli D; Azzini M; Stanzial AM; Guarini P; Friso S; De Franceschi L; Corrocher R
J Hypertens; 1995 Dec; 13(12 Pt 2):1823-6. PubMed ID: 8903660
[TBL] [Abstract][Full Text] [Related]
6. Hypertension prophylaxis with omega-3 fatty acids in heart transplant recipients.
Andreassen AK; Hartmann A; Offstad J; Geiran O; Kvernebo K; Simonsen S
J Am Coll Cardiol; 1997 May; 29(6):1324-31. PubMed ID: 9137231
[TBL] [Abstract][Full Text] [Related]
7. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK; Abbey M; Nestel PJ; Howe PR
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, randomized, double-blind, placebo-controlled, two-year trial to study the effect of nitrendipine on chronic renal transplant function.
Barenbrock M; Colmorgen U; Firschka E; Gellert J; Lippert J; Schröder K; Spieker C; Voigt-Ladner G; Wagner K; Neumayer HH
Clin Nephrol; 1995 Jun; 43(6):388-91. PubMed ID: 7554523
[TBL] [Abstract][Full Text] [Related]
10. Impact of parathyroidectomy on renal graft function, blood pressure and serum lipids in kidney transplant recipients: a single centre study.
Evenepoel P; Claes K; Kuypers D; Maes B; Vanrenterghem Y
Nephrol Dial Transplant; 2005 Aug; 20(8):1714-20. PubMed ID: 15919696
[TBL] [Abstract][Full Text] [Related]
11. Effect of n-3 polyunsaturated fatty acids on cyclosporine pharmacokinetics in kidney graft recipients: a randomized placebo-controlled study.
Busnach G; Stragliotto E; Minetti E; Perego A; Brando B; Broggi ML; Civati G
J Nephrol; 1998; 11(2):87-93. PubMed ID: 9589380
[TBL] [Abstract][Full Text] [Related]
12. The effects of amlodipine and enalapril on renal function in adults with hypertension and nondiabetic nephropathies: a 3-year, randomized, multicenter, double-blind, placebo-controlled study.
Esnault VL; Brown EA; Apetrei E; Bagon J; Calvo C; DeChatel R; Holdaas H; Krcmery S; Kobalava Z;
Clin Ther; 2008 Mar; 30(3):482-98. PubMed ID: 18405787
[TBL] [Abstract][Full Text] [Related]
13. Prevention of renal dysfunction and hypertension by amlodipine after heart transplant.
Leenen FH; Coletta E; Davies RA
Am J Cardiol; 2007 Aug; 100(3):531-5. PubMed ID: 17659942
[TBL] [Abstract][Full Text] [Related]
14. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
15. Fish oil as an adjuvant in the treatment of hypertension.
Gray DR; Gozzip CG; Eastham JH; Kashyap ML
Pharmacotherapy; 1996; 16(2):295-300. PubMed ID: 8820475
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
de la Sierra A; Gil-Extremera B; Calvo C; Campo C; García-Puig J; Márquez E; Oliván J; Roca Cusachs A; Sanz de Castro S; Pontes C; Delgadillo J
J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
[TBL] [Abstract][Full Text] [Related]
17. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
Vaïsse B; Ghobrial H; Vaur L; Poncelet P; Asmar R; Herpin D; Mallion JM
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
[TBL] [Abstract][Full Text] [Related]
18. Omega 3 polyunsaturated fatty acids supplementation and blood pressure levels in hypertriglyceridemic patients with untreated normal-high blood pressure and with or without metabolic syndrome: a retrospective study.
Cicero AF; Derosa G; Di Gregori V; Bove M; Gaddi AV; Borghi C
Clin Exp Hypertens; 2010 Jan; 32(2):137-44. PubMed ID: 20374188
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of cyclosporine on renal function in organ transplant recipients.
Bantle JP; Paller MS; Boudreau RJ; Olivari MT; Ferris TF
J Lab Clin Med; 1990 Feb; 115(2):233-40. PubMed ID: 2405085
[TBL] [Abstract][Full Text] [Related]
20. Effects of omega-3 fatty acids on resting heart rate, heart rate recovery after exercise, and heart rate variability in men with healed myocardial infarctions and depressed ejection fractions.
O'Keefe JH; Abuissa H; Sastre A; Steinhaus DM; Harris WS
Am J Cardiol; 2006 Apr; 97(8):1127-30. PubMed ID: 16616012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
